J3111
HCPCSInj. romosozumab-aqqg 1 mg
Official HCPCS Level II long descriptor
Injection, romosozumab-aqqg, 1 mg
HCPCS Level II code J3111 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj. romosozumab-aqqg 1 mg
Added to HCPCS: 2019-10-01
Nearby codes in J3
- J3055Inj talquetamab-tgvs 0.25 mg
- J3060Inj, taliglucerase alfa 10 u
- J3070Pentazocine injection
- J3090Inj tedizolid phosphate
- J3095Telavancin injection
- J3101Tenecteplase injection
- J3105Terbutaline sulfate inj
- J3110Teriparatide injection
- J3121Inj testostero enanthate 1mg
- J3145Testosterone undecanoate 1mg
- J3230Chlorpromazine hcl injection
- J3240Thyrotropin injection
- J3241Inj. teprotumumab-trbw 10 mg
- J3243Tigecycline injection
- J3244Inj. tigecycline (accord)
- J3245Inj., tildrakizumab, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.